tenofovir has been researched along with Chlamydia Infections in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, M; Andrew, P; Baepanye, K; Burns, D; Cohen, MS; Corey, L; Donnell, D; Edupuganti, S; Garnett, P; Gomez Lorenzo, MM; Greene, E; Hural, J; Juraska, M; Karg, C; Karuna, S; Kochar, N; Lazarus, E; Ledgerwood, J; Luthuli, N; Marshall, K; Mascola, JR; Mgodi, NM; Miner, MD; Mukwekwerere, PG; Rudnicki, E; Shava, E; Takuva, S; Tindale, I | 1 |
| Amico, KR; Anderson, PL; Bacon, O; Blue, RW; Buchbinder, S; Cardenas, G; Chege, W; Cohen, SE; Coleman, ME; Doblecki-Lewis, S; Elion, R; Estrada, Y; Feaster, DJ; Grant, R; Kolber, MA; Liegler, T; Liu, AY; Matheson, T; Philip, SS; Postle, BS; Rawlings, MK; Trainor, N; Vittinghoff, E | 1 |
| Brand, RM; Carballo-Diéguez, A; Cranston, RD; Dolezal, C; Duffill, K; Engstrom, JC; Febo, I; Frasca, T; Giguere, R; Jacobson, C; Leu, CS; Mayer, KH; McGowan, I; Nikiforov, A; Park, SY; Schwartz, JL; Siegel, A | 1 |
| Aubert, R; Dinh, C; Dobard, C; Garcia-Lerma, GJ; Hanson, D; Heneine, W; Henning, T; Kersh, E; Lipscomb, J; Makarova, N; McNicholl, J; Mitchell, J; Papp, J; Phillips, C; Taylor, A | 1 |
| Gaydos, CA; Hardick, A; Holden, J; Quinn, TC; Rizzo-Price, P; Wood, BJ | 1 |
2 trial(s) available for tenofovir and Chlamydia Infections
| Article | Year |
|---|---|
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
Topics: Adolescent; Adult; AIDS Vaccines; Antibodies, Monoclonal; Botswana; Broadly Neutralizing Antibodies; Chlamydia; Chlamydia Infections; Contraception; Double-Blind Method; Female; Gonorrhea; HIV Antibodies; HIV Infections; HIV-1; Humans; Incidence; Kenya; Malawi; Middle Aged; Mozambique; Prevalence; Sexually Transmitted Diseases; South Africa; Syphilis; Tenofovir; Trichomonas; Trichomonas Infections; Young Adult | 2021 |
Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women.
Topics: Administration, Rectal; Adolescent; Adult; Anti-HIV Agents; Chlamydia Infections; Cross-Sectional Studies; Female; Gels; Herpes Genitalis; HIV Infections; Homosexuality, Male; Humans; Male; Sexually Transmitted Diseases; Tenofovir; Transgender Persons; Young Adult | 2016 |
3 other study(ies) available for tenofovir and Chlamydia Infections
| Article | Year |
|---|---|
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Bisexuality; Chlamydia Infections; Community Health Services; District of Columbia; Female; Florida; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Middle Aged; Organophosphates; Pre-Exposure Prophylaxis; Prospective Studies; Reproductive Health; San Francisco; Sexual Behavior; Syphilis; Tenofovir; Transgender Persons; Unsafe Sex; Young Adult | 2016 |
Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.
Topics: Administration, Topical; Animals; Anti-HIV Agents; Chlamydia Infections; Coinfection; Disease Transmission, Infectious; Female; Macaca; Placebos; Plasma; Simian Acquired Immunodeficiency Syndrome; Tenofovir; Trichomonas Vaginitis; Vagina; Vaginal Creams, Foams, and Jellies | 2017 |
The microbicide tenofovir does not inhibit nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples.
Topics: Adenine; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Nucleic Acid Amplification Techniques; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Urine | 2008 |